These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 34347799)
1. Statins and the progression of age-related macular degeneration in the United States. Ludwig CA; Vail D; Rajeshuni NA; Al-Moujahed A; Rosenblatt T; Callaway NF; Veerappan Pasricha M; Ji MH; Moshfeghi DM PLoS One; 2021; 16(8):e0252878. PubMed ID: 34347799 [TBL] [Abstract][Full Text] [Related]
2. Role of statins in the development and progression of age-related macular degeneration. VanderBeek BL; Zacks DN; Talwar N; Nan B; Stein JD Retina; 2013 Feb; 33(2):414-22. PubMed ID: 23314233 [TBL] [Abstract][Full Text] [Related]
3. The association between statin use and risk of age-related macular degeneration. Ma L; Wang Y; Du J; Wang M; Zhang R; Fu Y Sci Rep; 2015 Dec; 5():18280. PubMed ID: 26658620 [TBL] [Abstract][Full Text] [Related]
4. [Use of statins as a form of protection against age-related macular degeneration (AMD)]. Drobek-Słowik M; Karczewicz D; Safranow K; Jakubowska K; Chlubek D Klin Oczna; 2008; 110(1-3):50-4. PubMed ID: 18669084 [TBL] [Abstract][Full Text] [Related]
5. Recent statin use and 1-year incidence of exudative age-related macular degeneration. Fong DS; Contreras R Am J Ophthalmol; 2010 Jun; 149(6):955-958.e1. PubMed ID: 20346439 [TBL] [Abstract][Full Text] [Related]
6. Statin use and the five-year incidence and progression of age-related macular degeneration. Klein R; Knudtson MD; Klein BE Am J Ophthalmol; 2007 Jul; 144(1):1-6. PubMed ID: 17475196 [TBL] [Abstract][Full Text] [Related]
7. Association of Ocular Antihypertensive Medications and the Development and Progression of Age-related Macular Degeneration in a U.S. Insurance Claims Database. Eton EA; Wubben TJ; Besirli CG; Wang SY Curr Eye Res; 2021 Jul; 46(7):995-1001. PubMed ID: 33174463 [No Abstract] [Full Text] [Related]
8. Unveiling Statins and Genetics in Age-Related Macular Degeneration: The Coimbra Eye Study-Report 9. Barreto P; Farinha C; Coimbra R; Cachulo ML; Melo JB; Lechanteur Y; Hoyng CB; Cunha-Vaz J; Silva R Invest Ophthalmol Vis Sci; 2024 Jun; 65(6):38. PubMed ID: 38935028 [TBL] [Abstract][Full Text] [Related]
9. Can HMG Co-A reductase inhibitors ("statins") slow the progression of age-related macular degeneration? The age-related maculopathy statin study (ARMSS). Guymer RH; Dimitrov PN; Varsamidis M; Lim LL; Baird PN; Vingrys AJ; Robman L Clin Interv Aging; 2008; 3(3):581-93. PubMed ID: 18982929 [TBL] [Abstract][Full Text] [Related]
10. Introducing Anti-Vascular Endothelial Growth Factor Therapies for AMD Did Not Raise Risk of Myocardial Infarction, Stroke, and Death. Yashkin AP; Hahn P; Sloan FA Ophthalmology; 2016 Oct; 123(10):2225-31. PubMed ID: 27523614 [TBL] [Abstract][Full Text] [Related]
11. Ten-Year Progression From Intermediate to Exudative Age-Related Macular Degeneration and Risk Factors: Bundang AMD Cohort Study Report 1. Joo K; Mun YS; Park SJ; Park KH; Woo SJ Am J Ophthalmol; 2021 Apr; 224():228-237. PubMed ID: 33279454 [TBL] [Abstract][Full Text] [Related]
12. The Question of a Role for Statins in Age-Related Macular Degeneration. Roizenblatt M; Naranjit N; Maia M; Gehlbach PL Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30469381 [TBL] [Abstract][Full Text] [Related]
13. [Neovascular recurrences in 42 treatment-naive eyes with neovascular age-related macular degeneration (AMD) followed for over 2 years]. Bodénès F; Massé H; Lebreton O; Weber M J Fr Ophtalmol; 2021 May; 44(5):626-631. PubMed ID: 33840491 [TBL] [Abstract][Full Text] [Related]
14. Age-related macular degeneration, anti-vascular endothelial growth factor agents, and short-term mortality: a postmarketing medication safety and surveillance study. French DD; Margo CE Retina; 2011 Jun; 31(6):1036-42. PubMed ID: 21836410 [TBL] [Abstract][Full Text] [Related]
16. Association of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular Degeneration. Dalvin LA; Starr MR; AbouChehade JE; Damento GM; Garcia M; Shah SM; Hodge DO; Meissner I; Bakri SJ; Iezzi R JAMA Ophthalmol; 2019 May; 137(5):483-490. PubMed ID: 30703203 [TBL] [Abstract][Full Text] [Related]
17. Effect of statins on the age of onset of age-related macular degeneration. Ganesh D; Chiang JN; Corradetti G; Zaitlen N; Halperin E; Sadda SR Graefes Arch Clin Exp Ophthalmol; 2023 Aug; 261(8):2245-2255. PubMed ID: 36917316 [TBL] [Abstract][Full Text] [Related]
18. Statins for age-related macular degeneration. Gehlbach P; Li T; Hatef E Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD006927. PubMed ID: 27490232 [TBL] [Abstract][Full Text] [Related]
19. Do statins have a role in the prevention of age-related macular degeneration? Tsao SW; Fong DS Drugs Aging; 2013 Apr; 30(4):205-13. PubMed ID: 23423861 [TBL] [Abstract][Full Text] [Related]
20. 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors and the presence of age-related macular degeneration in the Cardiovascular Health Study. McGwin G; Modjarrad K; Hall TA; Xie A; Owsley C Arch Ophthalmol; 2006 Jan; 124(1):33-7. PubMed ID: 16401782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]